Table 6.
The significance of the association of ESR with versus without individual clinical manifestations and pathergy reaction.
| ESR levels (mm/h) in patients with | ESR levels (mm/h) in patients without | |||||
|---|---|---|---|---|---|---|
| Manifestations | No. of patients | Median | (Range) | Median | (Range) | P-values |
| Oral ulcer | 31 | 21 | (2–95) | 12 | (2–70) | P = .113 |
| Genital ulcer | 23 | 22 | (2–95) | 14 | (2–60) | P = .121 |
| Ocular lesion | 18 | 22 | (2–86) | 14 | (2–95) | P = .291 |
| Vascular lesion | 37 | 20 | (2–70) | 14 | (2–95) | P = .642 |
| Arthritis/arthralgia | 25 | 22 | (3–60) | 14 | (2–95) | P = .317 |
| EN/PPE | 31 | 24 | (2–95) | 12 | (2–70) | P = .070 |
| (+) pathergy | 35 | 22 | (2–95) | 14 | (3–49) | P = .173 |
P* < .05 by Mann-Whitney U test (statistically significant with versus without clinical manifestations).
Data are presented as median values and their individual ranges within parentheses.